Carolina Livi

Title: Carolina Livi: Innovator in mTOR Inhibitor Research

Introduction

Carolina Livi is a prominent inventor based in San Antonio, TX (US). She has made significant contributions to the field of medical research, particularly in the area of mTOR inhibitors. With a total of 2 patents, her work focuses on innovative methods for preventing and treating intestinal polyps and cancer.

Latest Patents

Carolina Livi's latest patents include groundbreaking research on the use of mTOR inhibitors for the prevention of intestinal polyp growth and cancer. The first patent discloses methods and compositions for the treatment or prevention of intestinal polyps or cancer in patients identified as being at risk. This includes the use of rapamycin, a rapamycin analog, or other inhibitors of the target of rapamycin (TOR). The second patent similarly addresses the treatment of familial adenomatous polyposis, emphasizing the same innovative methods and compositions.

Career Highlights

Carolina Livi is affiliated with the University of Texas System, where she continues her research and development in the field of medical science. Her work has garnered attention for its potential impact on cancer prevention and treatment.

Collaborations

Some of her notable coworkers include Zelton Dave Sharp and Randy Strong, who contribute to her research endeavors.

Conclusion

Carolina Livi's innovative research in mTOR inhibitors represents a significant advancement in the prevention and treatment of intestinal polyps and cancer. Her contributions to the field are invaluable and continue to inspire future research.